Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — Strategic Asset Allocation Index
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Strategic Asset Allocation Index of 19.6% as of June 2023. Strategic assets (PP&E of CN¥1.46 Billion plus long-term investments of CN¥-) total CN¥1.46 Billion, measured against net assets of CN¥7.44 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Heilongjiang ZBD Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Heilongjiang ZBD Pharmaceutical Co Ltd Strategic Asset Allocation Index (2012–2021)
This chart shows how Heilongjiang ZBD Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 19.6%, representing strategic assets of CN¥1.46 Billion against net assets of CN¥7.44 Billion CNY. See financial agility of Heilongjiang ZBD Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Heilongjiang ZBD Pharmaceutical Co Ltd (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Heilongjiang ZBD Pharmaceutical Co Ltd from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Heilongjiang ZBD Pharmaceutical Co Ltd (603567) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.6% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥7.05 Billion | ▼ -5.9 pp |
| 2020 | 26.5% | CN¥1.46 Billion | CN¥1.46 Billion | CN¥- | CN¥5.50 Billion | ▼ -3.0 pp |
| 2019 | 29.5% | CN¥1.55 Billion | CN¥1.55 Billion | CN¥- | CN¥5.25 Billion | ▼ -20.7 pp |
| 2018 | 50.2% | CN¥2.50 Billion | CN¥2.44 Billion | CN¥60.65 Million | CN¥4.98 Billion | ▲ +8.6 pp |
| 2017 | 41.6% | CN¥1.95 Billion | CN¥1.89 Billion | CN¥60.00 Million | CN¥4.68 Billion | ▲ +9.0 pp |
| 2016 | 32.6% | CN¥1.40 Billion | CN¥1.34 Billion | CN¥60.00 Million | CN¥4.31 Billion | ▼ -2.0 pp |
| 2015 | 34.6% | CN¥1.38 Billion | CN¥1.32 Billion | CN¥61.00 Million | CN¥3.98 Billion | ▼ -27.4 pp |
| 2014 | 62.0% | CN¥1.35 Billion | CN¥1.35 Billion | CN¥- | CN¥2.17 Billion | ▼ -3.3 pp |
| 2013 | 65.3% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥1.75 Billion | ▼ -0.7 pp |
| 2012 | 66.0% | CN¥871.32 Million | CN¥871.32 Million | CN¥- | CN¥1.32 Billion | — |